Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.

Benzer Materyaller

• Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
  Yazar:: Labriola-Tompkins, E, ve diğerleri
  Baskı/Yayın Bilgisi: (1991)
• Ligand Promiscuity of Aryl Hydrocarbon Receptor Agonists and Antagonists Revealed by Site-Directed Mutagenesis
  Yazar:: Soshilov, Anatoly A., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Human P2Y(1) Receptor: Molecular Modeling and Site-Directed Mutagenesis as Tools To Identify Agonist and Antagonist Recognition Sites
  Yazar:: Moro, Stefano, ve diğerleri
  Baskı/Yayın Bilgisi: (1998)
• Site-directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding.
  Yazar:: Wess, J, ve diğerleri
  Baskı/Yayın Bilgisi: (1991)
• Elucidating Binding Sites and Affinities of ERα Agonists and Antagonists to Human Alpha-Fetoprotein by In Silico Modeling and Point Mutagenesis
  Yazar:: Moldogazieva, Nurbubu T., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)